Skip to content

PPP Versus Corticosteroid for Thigh Muscle Injuries

A Single Blind, Randomized Controlled Trial Evaluating Platelet Poor Plasma Versus Corticosteroid Injections as A Control for Thigh Muscle Injuries

Status
Enrolling by invitation
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07513142
Enrollment
30
Registered
2026-04-06
Start date
2026-03-25
Completion date
2028-06-01
Last updated
2026-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thigh Muscle Injury, Thigh Injury, Musculoskeletal, Musculoskeletal Injury Trauma, Musculoskeletal Injuries

Keywords

Thigh Muscle Injury, PPP, Platelet Poor Plasma, Corticosteroid, Sports Medicine, Orthopaedic, Orthopedic

Brief summary

The purpose of this study is to compare the number of days it takes for a sport participant to return to play between ultrasound guided intramuscular corticosteroid injections and platelet-poor plasma (PPP) injections for thigh muscle injuries.

Interventions

DRUGCorticosteroid

Only drug in the study

Only biologic in the study

Sponsors

Andrews Research & Education Foundation
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
15 Years to 30 Years
Healthy volunteers
No

Inclusion criteria

* 15-30 years of age (and) * Participant in a sport (and) * Confirmed thigh muscle injury

Exclusion criteria

* Patient is incapable or unwilling to provide informed consent. * Patient is not within the age range * Patient does not have a thigh injury * Patient's thigh injury occurred more than 4 weeks prior to treatment * Patient's thigh injury requires surgical intervention * Patient has had an injection for their thigh injury within the past 30 days * Patient has thrombocytosis or other platelet abnormality in whole blood

Design outcomes

Primary

MeasureTime frameDescription
Return to PlayUp to 1 yearNumber of days required for a patient to resume full, unrestricted, and asymptomatic participation in sports following the injection.
VAS Pain ScaleUp to 1 yearVisual Analog Scale (VAS) scores will be collected and analyzed at the following time points: immediately post-procedure, 24 hours, 2 weeks, 6 weeks, 12 weeks, and 1 year after the procedure. The Visual Analog Scale is a pain measurement to be obtained from the patient that ranges from 0 (no pain at all) to 10 (worst pain you can ever imagine).

Secondary

MeasureTime frameDescription
Modified BAMICPre-InjectionA secondary endpoint of this study includes characterization of the thigh injury using a modified version of the British Athletics Muscle Injury Classification (BAMIC) system.
Peak StrengthUp to 1 year post-injectionComparison of peak strength between the injured and uninjured thigh using a digital handheld dynamometer at the time of return-to-play clearance

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 10, 2026